ADTX - Aditxt to acquire women's health company Evofem Biosciences
2023-12-12 08:59:04 ET
More on Evofem Biosciences
- Evofem Biosciences expects to see third consecutive quarter of growth
- Evofem says no Phexxi generic until 2033 after company amends ANDA
- Financial information for Evofem Biosciences
For further details see:
Aditxt to acquire women’s health company Evofem Biosciences